Capital Advantage, Inc. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Advantage, Inc. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2021$45,000
-4.3%
13,0000.0%0.01%
-15.4%
Q3 2021$47,000
-17.5%
13,0000.0%0.01%
-13.3%
Q2 2021$57,000
-6.6%
13,000
-18.8%
0.02%
-16.7%
Q4 2020$61,000
+19.6%
16,0000.0%0.02%
+5.9%
Q3 2020$51,000
+15.9%
16,0000.0%0.02%
+6.2%
Q2 2020$44,000
-33.3%
16,000
-33.3%
0.02%
-38.5%
Q1 2020$66,000
-31.2%
24,0000.0%0.03%
-13.3%
Q4 2019$96,000
-15.8%
24,000
-29.4%
0.03%
-23.1%
Q3 2019$114,000
+10.7%
34,0000.0%0.04%
+5.4%
Q1 2019$103,000
+12.0%
34,0000.0%0.04%
+5.7%
Q4 2018$92,000
-19.3%
34,0000.0%0.04%
+34.6%
Q3 2018$114,000
+29.5%
34,0000.0%0.03%
+23.8%
Q2 2018$88,000
+17.3%
34,0000.0%0.02%
+16.7%
Q1 2018$75,000
+10.3%
34,0000.0%0.02%0.0%
Q4 2017$68,000
-38.2%
34,0000.0%0.02%
-35.7%
Q3 2017$110,00034,0000.03%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders